Fertiglobe has announced its financial results for the three-month and nine-month periods ending 30 September 2025 (“Q3 2025” and “9M 2025”). The company recorded robust third-quarter revenues of USD 758 million, marking a 53% year-on-year (Y-o-Y) increase. Adjusted EBITDA rose by 69% Y-o-Y to USD 286 million, while adjusted net profit attributable to shareholders reached USD 134 million — a sharp improvement compared to USD 28 million in the same quarter of 2024.
Ahmed El-Hoshy, CEO of Fertiglobe, stated: “I am proud of Fertiglobe’s strong third-quarter performance, which demonstrates the resilience of our integrated platform and reflects our commercial agility and disciplined cost management in a dynamic market. Despite gas supply constraints in Egypt, we capitalised on tight global urea markets, where prices rose 16% quarter-on-quarter (Q-o-Q) and 33% Y-o-Y to an average of USD 474 per tonne (FOB Egypt) in Q3 2025. We achieved record urea production volumes in Egypt, showcasing progress under our operational excellence strategy, which led to optimised margins and strong results.”
He added: “I am particularly encouraged by the strides made under our ‘Grow 2030 Strategy’, with approximately 38% of our growth targets already executed within six months, underscoring the strength of our delivery and potential for further gains. Our Manufacturing Improvement Plan (MIP) also continues to advance, with 43% of initiatives implemented towards our goal of generating USD 110–120 million in additional EBITDA by 2028 through improved energy and production efficiency. Moreover, with ADNOC’s support to reduce fixed costs by USD 19 million annually from 1 September 2025, we have now completed 84% of our cost reduction plan, achieving USD 46 million in savings by the end of Q3 2025. The completion of the Wengfu Australia acquisition in October 2025 — now independently funded after settling parent obligations within two months — alongside the expansion of DEF and AGU capacity in Egypt and the UAE, is expected to generate an additional USD 45 million in annual EBITDA by 2030. Our Commercial Excellence programme has also enabled us to secure higher price quartiles for our urea sales, delivering stronger premiums over benchmarks year-to-date.”
He concluded: “We remain firmly committed to realising our 2030 growth goals, supported by our majority shareholder and strong operational foundation. With the continued confidence of our employees, partners, and shareholders, Fertiglobe is well positioned to drive sustained growth and long-term value creation.”
